From: Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males
Parameter | Men | Women |
---|---|---|
BV/TV (%) | 10.7 ± 4.0 | 9.8 ± 3.8 |
BS/BV (mm2/mm3) | 22.1 ± 6.5 | 24.9 ± 8.5 |
Tb.N (number/mm) | 1.1 ± 0.3 | 1.1 ± 0.3 |
Tb.Sp (μm) | 900 ± 300 | 900 ± 300 |
Tb.Th (μm) | 100 ± 30 | 100 ± 30 |
OS/BS (%) | 5.6 ± 7.2 | 8.2 ± 10.5 |
ES/BS (%) | 2.3 ± 1.9 | 2.0 ± 1.2 |
Serum total RANKL (pmol/l) | 1,091 ± 781 | 1,688 ± 2471 |
Serum OPG (pmol/l) | 7.4 ± 2.0 | 7.4 ± 2.8 |
Serum ALP (U/l) | 92.9 ± 32.7 | 90.9 ± 19.7 |
Serum OCN (μg/l) | 6.0 ± 3.7 | 5.8 ± 2.9 |
Urinary DPD (nmol/mmol creatinine) | 18.3 ± 7.4 | 28.9 ± 7.5 |
Urinary PYR (nmol/mmol creatinine) | 73.7 ± 27.7 | 102.7 ± 33.7 |